DK131548B - Fremgangsmåde til fremstilling af kapsler indeholdende et kærnemateriale. - Google Patents

Fremgangsmåde til fremstilling af kapsler indeholdende et kærnemateriale.

Info

Publication number
DK131548B
DK131548B DK18070AA DK18070A DK131548B DK 131548 B DK131548 B DK 131548B DK 18070A A DK18070A A DK 18070AA DK 18070 A DK18070 A DK 18070A DK 131548 B DK131548 B DK 131548B
Authority
DK
Denmark
Prior art keywords
core material
capsules containing
making capsules
making
core
Prior art date
Application number
DK18070AA
Other languages
Danish (da)
English (en)
Inventor
M Kitajima
A Kondo
M Morishita
N Muroya
T Yamaguchi
Original Assignee
Fuji Photo Film Co Ltd
Toyo Jozo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP304269A external-priority patent/JPS4933738B1/ja
Application filed by Fuji Photo Film Co Ltd, Toyo Jozo Kk filed Critical Fuji Photo Film Co Ltd
Publication of DK131548B publication Critical patent/DK131548B/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/04—Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/06—Making microcapsules or microballoons by phase separation
    • B01J13/12—Making microcapsules or microballoons by phase separation removing solvent from the wall-forming material solution
    • B01J13/125—Making microcapsules or microballoons by phase separation removing solvent from the wall-forming material solution by evaporation of the solvent
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]
    • Y10T428/2985—Solid-walled microcapsule from synthetic polymer
    • Y10T428/2987—Addition polymer from unsaturated monomers only
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2989—Microcapsule with solid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicinal Preparation (AREA)
DK18070AA 1969-01-16 1970-01-15 Fremgangsmåde til fremstilling af kapsler indeholdende et kærnemateriale. DK131548B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP304269A JPS4933738B1 (de) 1969-01-16 1969-01-16
JP326069 1969-01-17

Publications (1)

Publication Number Publication Date
DK131548B true DK131548B (da) 1975-08-04

Family

ID=26336536

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18070AA DK131548B (da) 1969-01-16 1970-01-15 Fremgangsmåde til fremstilling af kapsler indeholdende et kærnemateriale.

Country Status (10)

Country Link
US (1) US3691090A (de)
BE (1) BE744162A (de)
CA (1) CA925380A (de)
CH (1) CH550606A (de)
CS (1) CS162703B2 (de)
DE (1) DE2001726A1 (de)
DK (1) DK131548B (de)
FR (1) FR2032314A1 (de)
GB (1) GB1275712A (de)
NL (1) NL7000343A (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK155036B (da) * 1977-08-05 1989-01-30 Battelle Memorial Institute Fremgangsmaade til fremstilling af oploesninger eller suspensioner af liposomer i vandige medier.

Families Citing this family (185)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854981A (en) * 1969-04-05 1974-12-17 Bayer Ag Process for embedding or enveloping solid materials
DE1938189A1 (de) * 1969-07-28 1971-02-25 Blendax Werke Schneider Co Enzymhaltige Zahn- und Mundpflegemittel
JPS4945130B1 (de) * 1970-08-17 1974-12-02
GB1322306A (en) * 1971-04-15 1973-07-04 Meiji Seika Co Stabilized antibiotic preparation and manufacturing process therefor
JPS5438164B2 (de) * 1972-05-29 1979-11-19
GB1468172A (en) * 1973-03-28 1977-03-23 Benzon As Alfred Oral drug preparations
GB1413186A (en) * 1973-06-27 1975-11-12 Toyo Jozo Kk Process for encapsulation of medicaments
GB1479268A (en) * 1973-07-05 1977-07-13 Beecham Group Ltd Pharmaceutical compositions
JPS5649956B2 (de) * 1973-08-17 1981-11-26
US4089800A (en) * 1975-04-04 1978-05-16 Ppg Industries, Inc. Method of preparing microcapsules
GB1509866A (en) * 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
US4020210A (en) * 1975-12-15 1977-04-26 Xerox Corporation Encapsulated water paper
JPS53124620A (en) * 1977-04-08 1978-10-31 Kureha Chem Ind Co Ltd Encapsulation of organic phosphoric acid pesticide
JPS5330988A (en) * 1977-06-29 1978-03-23 Toyo Jozo Co Ltd Activated carbon microcapsule
DE2812307A1 (de) * 1978-03-21 1979-10-04 Basf Ag Zubereitungen von dispersionsfarbstoffen
NL184440C (nl) 1978-05-17 1989-07-17 Battelle Memorial Institute Proefstrook voor het analyseren van opgeloste stoffen.
US4343790A (en) * 1979-02-06 1982-08-10 American Cyanamid Company Controlled release acrylic polymer coated granular pesticidal compositions with attendant reduced dermal toxicity
DE3013839A1 (de) * 1979-04-13 1980-10-30 Freunt Ind Co Ltd Verfahren zur herstellung einer aktivierten pharmazeutischen zusammensetzung
US4259445A (en) * 1979-06-01 1981-03-31 Cpc International Immobilized enzyme catalyst
US4485103A (en) * 1980-08-04 1984-11-27 American Cyanamid Company Controlled release acrylic polymer coated granular pesticidal compositions with attendant reduced dermal toxicity
US4389330A (en) * 1980-10-06 1983-06-21 Stolle Research And Development Corporation Microencapsulation process
US4798786A (en) * 1982-05-06 1989-01-17 Stolle Research And Development Corporation Living cells encapsulated in crosslinked protein
US4608401A (en) * 1982-09-02 1986-08-26 Union Carbide Corporation Method of encapsulating finely divided solid particles
USRE34145E (en) * 1982-09-02 1992-12-15 Union Carbide Chemicals & Plastics Technology Corporation Encapsulating finely divided solid particles in stable suspensions
US4771086A (en) * 1982-09-02 1988-09-13 Union Carbide Corporation Encapsulating finely divided solid particles in stable suspensions
US4536323A (en) * 1983-06-28 1985-08-20 The Drackett Company Non-flammable aerosol propellant microemulsion system
US4655959A (en) * 1983-06-28 1987-04-07 The Drackett Company Preparation of non-flammable aerosol propellant microemulsion system
EP0133353B1 (de) * 1983-07-26 1988-10-05 Fujikura Kasei Co., Ltd. Verfahren zur Herstellung druckfixierbarer Toner
US4670250A (en) * 1983-10-21 1987-06-02 Bend Research, Inc. Durable controlled release microcapsules
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
US4931207A (en) * 1984-01-27 1990-06-05 The Clorox Company Bleaching and bluing composition and method
US4952333A (en) * 1984-01-27 1990-08-28 The Clorox Company Bleaching and brightening composition and method
US5104571A (en) * 1984-01-27 1992-04-14 The Clorox Company Bleaching and brightening composition and method
US4708816A (en) * 1984-01-27 1987-11-24 The Clorox Company Bleach composition containing controlled density capsules
US4675140A (en) * 1984-05-18 1987-06-23 Washington University Technology Associates Method for coating particles or liquid droplets
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
DE3678308D1 (de) * 1985-02-07 1991-05-02 Takeda Chemical Industries Ltd Verfahren zur herstellung von mikrokapseln.
US4707287A (en) * 1985-06-28 1987-11-17 The Procter & Gamble Company Dry bleach stable enzyme composition
US4762637A (en) * 1986-11-14 1988-08-09 Lever Brothers Company Encapsulated bleach particles for machine dishwashing compositions
FR2608942B1 (fr) * 1986-12-31 1991-01-11 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanocapsules
FR2608988B1 (fr) * 1986-12-31 1991-01-11 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanoparticules
FR2634397B2 (fr) * 1986-12-31 1991-04-19 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une proteine sous forme de nanoparticules
US5912017A (en) * 1987-05-01 1999-06-15 Massachusetts Institute Of Technology Multiwall polymeric microspheres
US4861627A (en) * 1987-05-01 1989-08-29 Massachusetts Institute Of Technology Preparation of multiwall polymeric microcapsules
US4759956A (en) * 1987-05-22 1988-07-26 Lever Brothers Company Process for encapsulating particles using polymer latex
US4889562A (en) * 1987-06-16 1989-12-26 Ciba-Geigy Corporation Organic pigments coated with crosslinked ethyl cellulose
US4997599A (en) * 1987-12-08 1991-03-05 Celanese Fibers Inc. Preparation of water soluble cellulose acetate microspheres
US5460817A (en) * 1988-01-19 1995-10-24 Allied Colloids Ltd. Particulate composition comprising a core of matrix polymer with active ingredient distributed therein
GB8901254D0 (en) * 1989-01-20 1989-03-15 Allied Colloids Ltd Particulate materials and their production
US4867902A (en) * 1988-03-23 1989-09-19 Z-Gard, Inc. Microencapsulated oxygen generators
US5133965A (en) * 1988-06-08 1992-07-28 Fountain Pharmaceuticals, Inc. Dressing material having adsorbed thereon a solvent dilution microcarrier precursor solution
US5269979A (en) * 1988-06-08 1993-12-14 Fountain Pharmaceuticals, Inc. Method for making solvent dilution microcarriers
NO176278C (no) * 1988-08-24 1995-03-08 Allied Colloids Ltd Fremgangsmåte for fremstilling av en partikkelformig blanding av aktiv bestanddel i et polymert materiale
US4997590A (en) * 1988-12-22 1991-03-05 The Procter & Gamble Company Process of coloring stabilized bleach activator extrudates
US5116615A (en) * 1989-01-27 1992-05-26 Immunolytics, Inc. Method for treating benign prostatic hypertrophy
EP0456724B1 (de) 1989-01-27 1995-05-03 Immunolytics, Inc. Zusammensetzung und verfahren für die behandlung gutartiger prostata-hypertrophie
US5019400A (en) * 1989-05-01 1991-05-28 Enzytech, Inc. Very low temperature casting of controlled release microspheres
US5077051A (en) * 1990-04-10 1991-12-31 Warner-Lambert Company Sustained release of active agents from bioadhesive microcapsules
FR2663224B1 (fr) * 1990-06-14 1995-01-20 Applicationes Farmaceuticas Sa Forme galenique parenterale.
ES2034891B1 (es) * 1991-08-08 1993-12-16 Cusi Lab Procedimiento de elaboracion en continuo de sistemas coloidales dispersos, en forma de nanocapsulas o nanoparticulas.
JPH06511001A (ja) * 1991-09-19 1994-12-08 スミスクライン・ビーチャム・コーポレイション 接着生成物
US5209998A (en) * 1991-11-25 1993-05-11 Xerox Corporation Colored silica particles
ES2051214B1 (es) * 1992-02-27 1994-12-16 Quintela Manuel Arturo Lopez Procedimiento para la obtencion de nanoparticulas por polimerizacion en microemulsiones.
US5656297A (en) * 1992-03-12 1997-08-12 Alkermes Controlled Therapeutics, Incorporated Modulated release from biocompatible polymers
US5912015A (en) * 1992-03-12 1999-06-15 Alkermes Controlled Therapeutics, Inc. Modulated release from biocompatible polymers
EP0630234B1 (de) * 1992-03-12 1997-06-11 Alkermes Controlled Therapeutics, Inc. Acth enthaltende mikrokugeln mit gesteuerter abgabe
US5286495A (en) * 1992-05-11 1994-02-15 University Of Florida Process for microencapsulating cells
FR2693905B1 (fr) * 1992-07-27 1994-09-02 Rhone Merieux Procédé de préparation de microsphères pour la libération prolongée de l'hormone LHRH et ses analogues, microsphères et formulations obtenues.
GB9220706D0 (en) * 1992-10-01 1992-11-11 Allied Colloids Ltd Polymeric compositions
US6375872B1 (en) 1992-11-17 2002-04-23 Moore Business Forms Microencapsulated adhesive
TW333456B (en) * 1992-12-07 1998-06-11 Takeda Pharm Ind Co Ltd A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
US5981719A (en) * 1993-03-09 1999-11-09 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
GB9323634D0 (en) * 1993-11-16 1994-01-05 Warwick Int Ltd Bleach activator compositions
ATE288270T1 (de) * 1993-11-19 2005-02-15 Janssen Pharmaceutica Nv Mikroverkapselte 1,2-benzazole
US5650173A (en) * 1993-11-19 1997-07-22 Alkermes Controlled Therapeutics Inc. Ii Preparation of biodegradable microparticles containing a biologically active agent
ATE212830T1 (de) 1993-11-19 2002-02-15 Alkermes Inc Herstellung biologisch abbaubarer, einen biologisch aktiven stoff enthaltender, mikropartikel
IT1270216B (it) * 1994-06-14 1997-04-29 Recordati Chem Pharm Metodo di stabilizzazione di composti biologicamente attivi mediante microgranuli ricoperti sospendibili in fluidi alimentari
JPH10502270A (ja) * 1994-06-28 1998-03-03 クロージャー メディカル コーポレイション ｐＨ修整した生体適合性モノマー及びポリマー組成物
US6281015B1 (en) 1994-12-16 2001-08-28 Children's Medical Center Corp. Localized delivery of factors enhancing survival of transplanted cells
US5922253A (en) * 1995-05-18 1999-07-13 Alkermes Controlled Therapeutics, Inc. Production scale method of forming microparticles
CA2230494A1 (en) * 1995-08-31 1997-03-06 Alkermes Controlled Therapeutics Inc. Composition for sustained release of an agent
DE19545257A1 (de) 1995-11-24 1997-06-19 Schering Ag Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
US5792477A (en) * 1996-05-07 1998-08-11 Alkermes Controlled Therapeutics, Inc. Ii Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
US5989463A (en) * 1997-09-24 1999-11-23 Alkermes Controlled Therapeutics, Inc. Methods for fabricating polymer-based controlled release devices
US6194006B1 (en) 1998-12-30 2001-02-27 Alkermes Controlled Therapeutics Inc. Ii Preparation of microparticles having a selected release profile
US6204308B1 (en) 1999-03-01 2001-03-20 Novartis Ag Organic compounds
EP1044683A1 (de) * 1999-04-15 2000-10-18 Debio Recherche Pharmaceutique S.A. Einschrittdispersionsverfahren zur Mikroverkapselung von wasserlöslichen Substanzen
FR2795928B1 (fr) 1999-07-09 2001-09-07 Bourjois Article pour l'application d'une composition topique et son procede de preparation
AU6294800A (en) 1999-07-09 2001-01-30 Bourjois Article for applying a topical composition and method for preparing same
US7582311B1 (en) 1999-10-15 2009-09-01 Genentech, Inc. Injection vehicle for polymer-based formulations
US7651703B2 (en) * 1999-10-15 2010-01-26 Genentech, Inc. Injection vehicle for polymer-based formulations
US6705757B2 (en) * 1999-11-12 2004-03-16 Alkermes Controlled Therapeutics, Inc. Ii Method and apparatus for preparing microparticles using in-line solvent extraction
US6495166B1 (en) 1999-11-12 2002-12-17 Alkermes Controlled Therapeutics Inc. Apparatus and method for preparing microparticles using in-line solvent extraction
US6331317B1 (en) 1999-11-12 2001-12-18 Alkermes Controlled Therapeutics Ii Inc. Apparatus and method for preparing microparticles
US20010049375A1 (en) 2000-03-15 2001-12-06 Wolfgang Sadee Neutral antagonists and use thereof in treating drug abuse
AR023940A1 (es) 2000-05-03 2002-09-04 Eriochem Sa Procedimiento para la produccion de microcapsulas de liberacion prolongada de peptidos solubles en agua
US6264987B1 (en) * 2000-05-19 2001-07-24 Alkermes Controlled Therapeutics Inc. Ii Method for preparing microparticles having a selected polymer molecular weight
US6495164B1 (en) 2000-05-25 2002-12-17 Alkermes Controlled Therapeutics, Inc. I Preparation of injectable suspensions having improved injectability
US6306423B1 (en) 2000-06-02 2001-10-23 Allergan Sales, Inc. Neurotoxin implant
US20050214327A1 (en) * 2000-06-02 2005-09-29 Allergan, Inc. Neurotoxin-containing suppositories and related methods
US20040170665A1 (en) * 2000-06-02 2004-09-02 Allergan, Inc. Intravitreal botulinum toxin implant
US20040033241A1 (en) * 2000-06-02 2004-02-19 Allergan, Inc. Controlled release botulinum toxin system
US6719970B1 (en) 2000-07-10 2004-04-13 Alkermes Controlled Therapeutics, Inc. Method of generating cartilage
US6824822B2 (en) * 2001-08-31 2004-11-30 Alkermes Controlled Therapeutics Inc. Ii Residual solvent extraction method and microparticles produced thereby
US6471995B1 (en) 2000-09-27 2002-10-29 Alkermes Controlled Therapeutics, Inc. Ii Apparatus and method for preparing microparticles using liquid-liquid extraction
JP2004510730A (ja) 2000-10-06 2004-04-08 ヤゴテック　アーゲー 非経口的投与可能な制御放出微粒子調製物
SE517421C2 (sv) 2000-10-06 2002-06-04 Bioglan Ab Mikropartiklar, lämpade för parenteral administration, väsentligen bestående av stärkelse med minst 85 % amylopektin och med reducerad molekylvikt, samt framställning därav
SE517422C2 (sv) * 2000-10-06 2002-06-04 Bioglan Ab Farmaceutiskt acceptabel stärkelse
SE518008C2 (sv) * 2000-11-16 2002-08-13 Bioglan Ab Parenteralt administrerbara mikropartiklar och förfarande för framställning av desamma
SE518007C2 (sv) 2000-11-16 2002-08-13 Bioglan Ab Förfarande för framställning av mikropartiklar
WO2002049620A2 (en) 2000-12-21 2002-06-27 Inhale Therapeutic Systems, Inc. Induced phase transition method for the production of microparticles containing hydrophobic active agents
US20020114843A1 (en) * 2000-12-27 2002-08-22 Ramstack J. Michael Preparation of microparticles having improved flowability
US6558702B2 (en) * 2001-04-13 2003-05-06 Alkermes Controlled Therapeutics, Inc. Method of modifying the release profile of sustained release compositions
US20060269602A1 (en) * 2001-04-13 2006-11-30 Dasch James R Method of modifying the release profile of sustained release compositions
US7105181B2 (en) * 2001-10-05 2006-09-12 Jagotec, Ag Microparticles
US20030084914A1 (en) * 2001-11-08 2003-05-08 L'oreal Cosmetic articles having encapsulated liquid and method of making same
DE10163142A1 (de) 2001-12-20 2003-07-10 Henkel Kgaa Polymere Duftkapseln und ihre Herstellung
AU2002351749A1 (en) * 2001-12-21 2003-07-15 Novozymes A/S Salt coatings
US7838619B2 (en) * 2002-01-14 2010-11-23 The General Hospital Corporation Biodegradable polyketal polymers and methods for their formation and use
JP2005517012A (ja) * 2002-02-08 2005-06-09 アルカーメス コントロールド セラピューティクス，インコーポレイテッド 持続放出のためのポリマーベース組成物
SE0201599D0 (sv) * 2002-03-21 2002-05-30 Skyepharma Ab Microparticles
US7041320B1 (en) 2002-05-31 2006-05-09 Biotek, Inc. High drug loaded injectable microparticle compositions and methods of treating opioid drug dependence
US7157102B1 (en) 2002-05-31 2007-01-02 Biotek, Inc. Multi-layered microcapsules and method of preparing same
US7164005B2 (en) * 2002-10-17 2007-01-16 Alkermes, Inc. Microencapsulation and sustained release of biologically active polypeptides
US20040086532A1 (en) * 2002-11-05 2004-05-06 Allergan, Inc., Botulinum toxin formulations for oral administration
US20040253274A1 (en) * 2003-06-11 2004-12-16 Allergan, Inc. Use of a clostridial toxin to reduce appetite
US8591972B2 (en) 2005-05-23 2013-11-26 Kraft Foods Global Brands Llc Delivery system for coated active components as part of an edible composition
US9271904B2 (en) 2003-11-21 2016-03-01 Intercontinental Great Brands Llc Controlled release oral delivery systems
US8389032B2 (en) 2005-05-23 2013-03-05 Kraft Foods Global Brands Llc Delivery system for active components as part of an edible composition having selected particle size
US20050112236A1 (en) 2003-11-21 2005-05-26 Navroz Boghani Delivery system for active components as part of an edible composition having preselected tensile strength
US8591973B2 (en) 2005-05-23 2013-11-26 Kraft Foods Global Brands Llc Delivery system for active components and a material having preselected hydrophobicity as part of an edible composition
US8597703B2 (en) 2005-05-23 2013-12-03 Kraft Foods Global Brands Llc Delivery system for active components as part of an edible composition including a ratio of encapsulating material and active component
US8591974B2 (en) * 2003-11-21 2013-11-26 Kraft Foods Global Brands Llc Delivery system for two or more active components as part of an edible composition
US8591968B2 (en) 2005-05-23 2013-11-26 Kraft Foods Global Brands Llc Edible composition including a delivery system for active components
EP2409707B8 (de) 2004-04-15 2015-05-06 Alkermes Pharma Ireland Limited Vorrichtung auf Polymerbasis mit verzögerter Freisetzung
US7456254B2 (en) * 2004-04-15 2008-11-25 Alkermes, Inc. Polymer-based sustained release device
US20060110423A1 (en) * 2004-04-15 2006-05-25 Wright Steven G Polymer-based sustained release device
US7691381B2 (en) 2004-04-15 2010-04-06 Allergan, Inc. Stabilized biodegradable neurotoxin implants
US20050238618A1 (en) * 2004-04-23 2005-10-27 Yujin Huang Low molecular weight polymers
WO2005107714A2 (en) * 2004-05-05 2005-11-17 Alkermes Controlled Therapeutics, Inc. Method of forming microparticles that include a bisphosphonate and a polymer
US20060024340A1 (en) * 2004-07-30 2006-02-02 Elder Stewart T Encapsulated fluorescent whitening compositions for improved surface appearance
US7341743B2 (en) * 2004-10-28 2008-03-11 Revlon Consumer Products Corporation Color cosmetic compositions
US20080213593A1 (en) * 2005-01-21 2008-09-04 President And Fellows Of Harvard College Systems And Methods For Forming Fluidic Droplets Encapsulated In Particles Such As Colloidal Particles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
US20070020209A1 (en) * 2005-07-20 2007-01-25 Tatyana Zamyatin Makeup compositions and methods
US7914891B2 (en) 2005-12-28 2011-03-29 Kimberly-Clark Worldwide, Inc. Wipes including microencapsulated delivery vehicles and phase change materials
US20070148459A1 (en) * 2005-12-28 2007-06-28 Kimberly-Clark Worldwide, Inc. Microencapsulated delivery vehicles
US7654412B2 (en) * 2006-05-30 2010-02-02 Kimberly-Clark Worldwide, Inc. Wet wipe dispensing system for dispensing warm wet wipes
US7497351B2 (en) 2006-05-30 2009-03-03 Kimberly-Clark Worldwide, Inc. Wet wipe dispensing system
US7648046B2 (en) * 2006-05-30 2010-01-19 Kimberly-Clark Worldwide, Inc. Dispensing system for dispensing warm wet wipes
AU2007284759B2 (en) 2006-08-09 2010-10-28 Intarcia Therapeutics, Inc. Osmotic delivery systems and piston assemblies
JP5302888B2 (ja) * 2006-08-31 2013-10-02 エスケー ケミカルズ カンパニー リミテッド 薬物含有高分子微小球の製造方法及びその方法により製造された薬物含有高分子微小球
US20080145437A1 (en) * 2006-12-14 2008-06-19 Kimberly-Clark Worldwide, Inc. Reactive Chemistries For Warming Personal Care Products
US7517582B2 (en) * 2006-12-14 2009-04-14 Kimberly-Clark Worldwide, Inc. Supersaturated solutions using crystallization enthalpy to impart temperature change to wet wipes
US8192841B2 (en) 2006-12-14 2012-06-05 Kimberly-Clark Worldwide, Inc. Microencapsulated delivery vehicle having an aqueous core
US7597954B2 (en) * 2006-12-14 2009-10-06 Kimberly-Clark Worldwide, Inc. Supersaturated solutions using crystallization enthalpy to impact temperature change to wet wipes
US20080233199A1 (en) * 2007-03-22 2008-09-25 Alkermes, Inc. Coacervation Process
AU2008244523B2 (en) 2007-04-23 2012-02-16 Intarcia Therapeutics, Inc. Suspension formulations of insulinotropic peptides and uses thereof
US20080317865A1 (en) * 2007-06-20 2008-12-25 Alkermes, Inc. Quench liquids and washing systems for production of microparticles
WO2009051824A2 (en) 2007-10-18 2009-04-23 Aiko Biotechnology Combination analgesic employing opioid and neutral antagonist
US8748448B2 (en) 2007-10-18 2014-06-10 Aiko Biotechnology Combination analgesic employing opioid agonist and neutral antagonist
EP2240155B1 (de) 2008-02-13 2012-06-06 Intarcia Therapeutics, Inc Vorrichtungen, formulierungen und verfahren zur freisetzung mehrerer wirkstoffe
GB0909280D0 (en) 2009-06-01 2009-07-15 Ciba Holding Inc Wall form system
GB0911562D0 (en) 2009-07-03 2009-08-12 Basf Se Foam composition
RU2012102083A (ru) * 2009-07-10 2013-08-20 Дзе Проктер Энд Гэмбл Компани Композиции, содержащие частицы для доставки агентов, оказывающих благоприятное воздействие
RU2547990C2 (ru) 2009-09-28 2015-04-10 Интарсия Терапьютикс, Инк. Быстрое достижение и/или прекращение существенной стабильной доставки лекарственного средства
AR083328A1 (es) 2010-07-20 2013-02-21 Procter & Gamble Particula de suministro
WO2012014052A2 (en) * 2010-07-30 2012-02-02 Micro Labs Limited Novel coated extended release pharmaceutical compositions containing paliperidone
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
WO2012134441A1 (en) 2011-03-29 2012-10-04 Empire Technology Development Llc Microcapsule corrosion control in reinforced concrete
MX2016004035A (es) 2013-09-30 2016-06-02 Zoetis Services Llc Formulaciones de espiro-isoxazolina de accion prolongada.
EP2926659A1 (de) 2014-04-04 2015-10-07 LANXESS Deutschland GmbH Biozide Mittel
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
EP3302354B1 (de) 2015-06-03 2023-10-04 i2o Therapeutics, Inc. Systeme zum einsetzen eines implantats
RU2760007C2 (ru) 2016-05-16 2021-11-22 Интарсия Терапьютикс, Инк. Полипептиды, селективные к рецепторам глюкагона, и способы их применения
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
WO2018129058A1 (en) 2017-01-03 2018-07-12 Intarcia Therapeutics, Inc. Methods comprising continuous administration of a glp-1 receptor agonist and co-adminstration of a drug
US11007134B1 (en) 2020-03-31 2021-05-18 L'oreal Ceramide containing capsules, ceramide compositions, and cosmetic compositions thereof
FR3113244B1 (fr) 2020-08-07 2023-03-17 Oreal Capsules contenant du céramide, compositions de céramide, et compositions cosmétiques associées
WO2021202493A1 (en) 2020-03-31 2021-10-07 L'oreal Ceramide containing capsules, ceramide compositions, and cosmetic compositions thereof
FR3113833B1 (fr) 2020-09-08 2023-12-01 Oreal Composition cosmetique contenant du retinol
WO2022006032A1 (en) 2020-06-30 2022-01-06 L'oreal Cosmetic composition having retinol
IT202000030848A1 (it) * 2020-12-15 2022-06-15 Zobele Holding Spa Diffusore di sostanze liquide volatili munito di una membrana permeabile ai vapori e attivabile al momento dell’uso

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE24899E (en) * 1953-06-30 1960-11-29 Oil-containrab
US3016308A (en) * 1957-08-06 1962-01-09 Moore Business Forms Inc Recording paper coated with microscopic capsules of coloring material, capsules and method of making
US3173878A (en) * 1960-02-26 1965-03-16 Ibm Process of making microcapsules
US3415758A (en) * 1960-03-09 1968-12-10 Ncr Co Process of forming minute capsules en masse
DE1228757B (de) * 1962-06-28 1966-11-17 Haessle Ab Verfahren zur Herstellung eines in Wasser und Magensaft rasch zerfallenden UEberzuges auf festen Arzneiformen
NL137652C (de) * 1962-07-11

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK155036B (da) * 1977-08-05 1989-01-30 Battelle Memorial Institute Fremgangsmaade til fremstilling af oploesninger eller suspensioner af liposomer i vandige medier.

Also Published As

Publication number Publication date
BE744162A (fr) 1970-06-15
US3691090A (en) 1972-09-12
DE2001726A1 (de) 1970-07-23
CS162703B2 (de) 1975-07-15
CH550606A (de) 1974-06-28
NL7000343A (de) 1970-07-20
FR2032314A1 (de) 1970-11-27
GB1275712A (en) 1972-05-24
CA925380A (en) 1973-05-01

Similar Documents

Publication Publication Date Title
DK131548B (da) Fremgangsmåde til fremstilling af kapsler indeholdende et kærnemateriale.
DK140623B (da) Fremgangsmåde til fremstilling af mikrokapsler.
FI45575C (fi) Selluloosapitoisen aineen käsittelymenetelmä.
DK125526B (da) Fremgangsmåde til fremstilling af et katalysatormateriale.
DK125372B (da) Fremgangsmåde til massefremstilling af små kapsler.
DK139035B (da) Fremgangsmåde til fremstilling af et kærnegarn.
DK124559B (da) Fremgangsmåde til påføring af kapsler på et underlag.
DK134045B (da) Fremgangsmåde til fremstilling af et pulverpræparat til fremstilling af drikkevarer.
DK131471B (da) Fremgangsmåde til fremstilling af et streptokinaseholdigt materiale.
DK130874B (da) Fremgangsmåde til fremstilling af mikrokapsler.
DK125188B (da) Fremgangsmåde til fremstilling af små kapsler.
DK131132B (da) Fremgangsmåde til fremstilling af små kapsler.
DK123012B (da) Fremgangsmåde ved fremstilling af en todelt flaskekapsel.
DK125527B (da) Fremgangsmåde til fremstilling af små kapsler.
DK128424B (da) Fremgangsmåde til fremstilling af et båndagtigt materiale.
DK131053B (da) Fremgangsmåde til fjernelse af uønsket materiale fra et borehul.
DK123460B (da) Fremgangsmåde til fremstilling af små kapsler.
DK114785B (da) Fremgangsmåde til fremstilling af et porøst elektrodemateriale.
DK130576B (da) Fremgangsmåde til fremstilling af et formgivet katalysatormateriale.
DK118377B (da) Fremgangsmåde til fremstilling af en hermetisk kapsel.
DK129298B (da) Fremgangsmåde til fremstilling af et stoppemateriale af syntetiske filamenter.
DK125545B (da) Fremgangsmåde til fremstilling af et stopningsmateriale.
DK131255B (da) Fremgangsmåde til fremstilling af et LeClanche tørelement.
DK131327B (da) Fremgangsmåde til fremstilling af mikrokapsler.
DK132073B (da) Fremgangsmåde til at gøre en glasgenstand splintfri.